ProMIS Neurosciences, Inc. (PMN)
ProMIS Neurosciences Market Cap: 15.07M for Dec. 31, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 95.86M |
| Aurinia Pharmaceuticals, Inc. | 2.096B |
| Edesa Biotech, Inc. | 10.19M |
| Lexaria Bioscience Corp. | 13.94M |
| Xenon Pharmaceuticals, Inc. | 3.457B |
Market Cap Related Metrics
| PEG Ratio | -0.0001 |
| Price to Book Value | 1.640 |
| Price | 7.00 |
| Earnings Yield | -194.0% |
| PEGY Ratio | -0.0001 |